Mike’s Sleep Apnea Disrupted His Sleep and Lifestyle Until He Found a Therapy Offered at His Local VA Hospital
Mike shares how the daily disruptions caused by his undiagnosed CSA led him to a sleep study and an eventual treatment.
LEARNING TO
SLEEP BETTER
Mike shares how the daily disruptions caused by his undiagnosed CSA led him to a sleep study and an eventual treatment.
A large community-based study was conducted to test the prevalence of a particular form of central sleep apnea (CSA): CSA and cheyne-stokes respiration (CSR) using current clinical definitions. The study was unique in that it was conducted in a community setting instead of a controlled clinical environment
For people with central sleep apnea, understanding exactly which treatment options are covered under your insurance policy can be time- consuming. Every insurance plan is different, but this blog is designed to help those of you with Medicare Advantage or Commercial insurance understand the prior authorization process that will determine coverage eligibility.
Excessive daytime sleepiness (EDS) is a potential symptom of sleep apnea. This blog will focus specifically on how daytime sleepiness impacts people with central sleep apnea (CSA).
Alan shares his long-time struggle with lack of sleep and the different treatment options he explored until he finally found relief.
The remedē® system is indicated for moderate to severe Central Sleep Apnea in adult patients.
Your doctor will need to evaluate your condition to determine if the remedē system is right for you. You will not be able to have an MRI or diathermy (special heat therapies) if you have the remedē system implanted. The remedē System may be used if you have another stimulation device such as a heart pacemaker or defibrillator; special testing will be needed to ensure the devices are not interacting.
As with any surgically implanted device, there are risks related to the surgical procedure itself which may include, but are not limited to, pain, swelling, and infection.
Once the therapy is turned on, some patients may experience discomfort from stimulation and/or from the presence of the device. The majority of these events are resolved either on their own or by adjusting the therapy settings. The remedē system may not work for everyone. There are additional risks associated with removing your system. If you and your doctor decide to remove the system, another surgery will be required.
Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the remedē System. Rx only. For further information, please visit remede.zoll.com, call +1-952-540-4470 or email info@remede.zoll.com.
The remedē® System, remedē® EL System, and remedē® EL-X System have received FDA approval. The remedē® System model 1001 has received CE Mark approval.
Copyright © 2021 ZOLL Medical Corporation. All rights reserved. Respicardia and remedē are registered trademarks of ZOLL Respicardia, Inc. in the United States and/or other countries. ZOLL is a registered trademark of ZOLL Medical Corporation in the United States and/or other countries.